This study is looking at how well a device called MuVI Esophageal mucosal impedance testing can help diagnose common conditions like GERD (Gastroesophageal reflux disease) and Eosinophilic Esophagitis (EoE). These conditions can be hard to diagnose, often requiring multiple tests. The study aims to see if using the MuVI device can make diagnosis easier and faster. You may be able to join if you are an adult (18 or older) with ongoing esophageal symptoms like reflux or difficulty swallowing, and are scheduled for an upper endoscopy. You cannot participate if you have an esophageal stricture, esophageal cancer, are pregnant, or are on certain blood thinners on the day of the procedure. The study will measure how accurate and useful the MuVI device is in diagnosing these conditions over one year.

Study design

This is an observational study with a planned enrollment of 50 participants. It is not specified if the study is randomized or blinded.

What's involved

You would undergo MuVI Esophageal mucosal impedance testing. The study aims to measure diagnostic accuracy and utility over one year.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoints are measured at 1 year, suggesting a follow-up period of at least one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.